As an ISCRM Fellow, Hailemikael Yirdaw will develop and test designed protein scaffolds that greatly enhance the sensitivity of CAR T cells to tumor antigens. Achieving a new generation of CARs with improved sensitivity would open the door to more effective therapeutics for a wide variety of tumors.